Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for United Health Products, Inc. (UEEC : OTC)

• Company Description    United Health Products, Inc. develop, manufactures and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and control bleeding. It serves dental and medical markets. United Health Products, Inc. is based in Henderson, Nevada. Number of Employees: 7

• Price / Volume Information    Yesterday's Closing Price: $0.56 Daily Weekly Monthly 20 Day Moving Average: 148,004 shares Shares Outstanding: 230.08 (millions) Market Capitalization: $128.84 (millions) Beta: -0.81 52 Week High: $1.25 52 Week Low: $0.35 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.67% 31.39% 12 Week 19.15% 30.98% Year To Date -5.08% 23.20%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10624 S. EASTERN AVE. SUITE A209 - HENDERSON,NV 89052 USA ph: 877-358-3444 fax: - p.niemetz@panconsultants.com http://www.unitedhealthproductsinc.com

• General Corporate Information    Officers Brian Thom - Chief Executive Officer; and Director Kristofer Heaton - Vice President of Finance and Principal Financial Robert Denser - Director Louis Schiliro - Director Robert Denser - Director Peer Information United Health Products, Inc. (BJCT) United Health Products, Inc. (CADMQ) United Health Products, Inc. (APNO) United Health Products, Inc. (UPDC) United Health Products, Inc. (IMTIQ) United Health Products, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 91059D100 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/21 Next Expected EPS Date: 05/25/22 Share - Related Items Shares Outstanding: 230.08 Most Recent Split Date: (:1) Beta: -0.81 Market Capitalization: $128.84 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/25/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 66.67% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - -2,849.52 12/31/21 - -12,912.20 09/30/21 - -12,052.82 Current Ratio 03/31/22 - 0.02 12/31/21 - 0.02 09/30/21 - 0.19 Quick Ratio 03/31/22 - - 12/31/21 - 0.02 09/30/21 - 0.13 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - -0.01 12/31/21 - 0.00 09/30/21 - 0.00 Inventory Turnover 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©